CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia
- PMID: 3496802
- DOI: 10.1176/ajp.144.7.873
CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia
Abstract
To further investigate the hypothesis that hyperactivity of the hypothalamic-pituitary-adrenal axis in patients with depression may be mediated by hypersecretion of corticotropin-releasing factor (CRF), the authors measured CRF-like immunoreactivity in CSF samples from 138 neurological control, 54 depressed, and 27 nondepressed (23 schizophrenic and four manic) subjects. The CSF CRF concentration was markedly higher (almost twofold) in depressed patients than in control subjects and nondepressed psychiatric patients. The concentration of CSF CRF was slightly but significantly higher in schizophrenic patients than in control subjects. These findings provide further support for the hypothesis that CRF hypersecretion occurs in major depression.
Similar articles
-
Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients.Science. 1984 Dec 14;226(4680):1342-4. doi: 10.1126/science.6334362. Science. 1984. PMID: 6334362
-
CSF corticotropin-releasing hormone in depressed patients and normal control subjects.Am J Psychiatry. 1987 May;144(5):641-5. doi: 10.1176/ajp.144.5.641. Am J Psychiatry. 1987. PMID: 3495188
-
Limbic-hypothalamic-pituitary-adrenal axis activity and ventricular-to-brain ratio studies in affective illness and schizophrenia.Neuropsychopharmacology. 1992 Feb;6(2):95-100. Neuropsychopharmacology. 1992. PMID: 1319168
-
The role of corticotropin-releasing factor in the pathogenesis of major depression.Pharmacopsychiatry. 1988 Mar;21(2):76-82. doi: 10.1055/s-2007-1014652. Pharmacopsychiatry. 1988. PMID: 3293091 Review.
-
Postmortem and cerebrospinal fluid studies of corticotropin-releasing factor in humans.Ann N Y Acad Sci. 1996 Mar 22;780:96-105. doi: 10.1111/j.1749-6632.1996.tb15114.x. Ann N Y Acad Sci. 1996. PMID: 8602742 Review. No abstract available.
Cited by
-
By what molecular mechanisms do social determinants impact cardiometabolic risk?Clin Sci (Lond). 2023 Mar 31;137(6):469-494. doi: 10.1042/CS20220304. Clin Sci (Lond). 2023. PMID: 36960908 Free PMC article. Review.
-
The Hypothalamic-Pituitary-Adrenal Axis in Major Depressive Disorder: A Brief Primer for Primary Care Physicians.Prim Care Companion J Clin Psychiatry. 2001 Aug;3(4):151-155. doi: 10.4088/pcc.v03n0401. Prim Care Companion J Clin Psychiatry. 2001. PMID: 15014598 Free PMC article.
-
Neuropeptides involved in the pathophysiology of schizophrenia and major depression.Neurotox Res. 2002 Aug-Sep;4(5-6):453-468. doi: 10.1080/10298420290031432. Neurotox Res. 2002. PMID: 12754159
-
Regulation of serotonin release in the lateral septum and striatum by corticotropin-releasing factor.J Neurosci. 2001 Apr 15;21(8):2833-41. doi: 10.1523/JNEUROSCI.21-08-02833.2001. J Neurosci. 2001. PMID: 11306635 Free PMC article.
-
Perturbations in Effort-Related Decision-Making Driven by Acute Stress and Corticotropin-Releasing Factor.Neuropsychopharmacology. 2016 Jul;41(8):2147-59. doi: 10.1038/npp.2016.15. Epub 2016 Feb 2. Neuropsychopharmacology. 2016. PMID: 26830960 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical